Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Form 13F-NT Nomura Asset Management For: Sep 30
-
Form 13F-NT Nomura Islamic Asset For: Sep 30
-
Form 13F-NT NOMURA ASSET MANAGEMENT For: Sep 30
-
Form 13F-NT Nomura Asset Management For: Sep 30
-
Form 13F-NT Nomura Asset Management For: Sep 30
-
Form 13F-HR NOMURA ASSET MANAGEMENT For: Sep 30
-
Form 13F-NT NOMURA SECURITIES CO For: Sep 30
-
Form 13F-NT NOMURA SECURITIES BERMUD For: Sep 30
-
Form 13F-NT NOMURA INTERNATIONAL For: Sep 30
-
Form 13F-NT NOMURA SECURITIES INTERN For: Sep 30
-
Form 13F-NT NOMURA GLOBAL FINANCIAL For: Sep 30
-
Form 13F-HR NOMURA HOLDINGS INC For: Sep 30
-
Sosei Heptares Operational Highlights and Consolidated Results for the Nine Months ended 30 September 2020
-
Analysis: Japanese stocks catch global investors' eyes as post-COVID growth play
-
Whole Earth Brands (FREE) Acquires Swerve
-
Whole Earth Brands, Inc. Acquires Swerve®, a Rapidly Growing Keto-Friendly & Plant-based Sweeteners & Baking Brand
-
Whole Earth Brands, Inc. Acquires Swerve®, a Rapidly Growing Keto-Friendly & Plant-based Sweeteners & Baking Brand
-
China's exports seen maintaining momentum; import growth cools: Reuters poll
-
Toyota, Honda double profit outlook as China rebounds from pandemic
-
Vincent Turcotte joins Eventus Systems as Sales Director, Asia Pacific
-
Form 6-K NOMURA HOLDINGS INC For: Nov 05
-
China considers 5% annual GDP growth target for next five years: sources
-
Wall Street turns on pollsters as U.S election leaves markets in limbo
-
No wild ride: FX swings fall as extreme dollar bets unwound
-
DeFi Project KingSwap Achieves $4 Million in Transaction Volume in First Three Days on Uniswap
-
DeFi Project KingSwap Achieves $4 Million in Transaction Volume in First Three Days on Uniswap
-
Freddie Mac Prices New $3 Billion Three-Year Reference Notes Security
-
Freddie Mac Announces Issuance of New Three-Year Reference Notes Security
-
Leslie's, Inc. Announces Closing Of Initial Public Offering
-
Sosei Heptares and Aditum Bio create new company - Tempero Bio - to advance the clinical development of mGlu5 NAM program in neurological diseases
-
Dollar gains as investors cautious before U.S. election
-
First Regulated DeFi Project KingSwap Raises $20 Million in Funding and Liquidity Support, Announces Public Launch on Uniswap
-
First Regulated DeFi Project KingSwap Raises $20 Million in Funding and Liquidity Support, Announces Public Launch on Uniswap
-
MHI to Issue First Green Bond
-
IPO for Pool-Company Leslie's (LESL) Opens 21% Higher
-
Leslie's Inc. (LESL) Prices 40M Share IPO at $17/Sh
-
Leslie's, Inc. Announces Pricing Of Initial Public Offering
-
Freddie Mac Prices Approximately $1.7 Billion Securitization of Re-Performing Loans
-
Christie introduces groundbreaking far-UVC light fixture with patented Care222 technology for UV disinfection that may be used around people
-
I-Mab Announces Upcoming Participation at November Conferences
-
Christie introduces groundbreaking far-UVC light fixture with patented Care222 technology for UV disinfection that may be used around people
-
Zai Lab Announces Upcoming Presentations in November Investor Conferences
-
Zai Lab Announces Upcoming Presentations in November Investor Conferences
-
Bitwise Surpasses $100 Million In Assets Under Management Due To Rising Demand For Crypto From Hedge Funds And Financial Advisors
-
Form 6-K NOMURA HOLDINGS INC For: Oct 28
-
Form 6-K NOMURA HOLDINGS INC For: Oct 28
-
First Regulated DeFi Project KingSwap Launches Halloween-Themed NFTs
-
First Regulated DeFi Project KingSwap Launches Halloween-Themed NFTs
-
Exelixis (EXEL), Takeda Pharma & Ono Pharma Report Submission of Supplemental Application for CABOMETYX (cabozantinib) in Combination with OPDIVO (nivolumab) in Japan
-
Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) for the Treatment of Unresectable, Advanced or Metastatic Rena

